Article Details
Retrieved on: 2025-02-05 21:22:25
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article describes Jabil Inc.'s acquisition of Pharmaceutics International, a biopharma contract development and manufacturing organization. Key players like Athyrium Capital Management and Pharmascience Inc. exited their investment. This supports Jabil's biopharma expansion. Tags reflect biopharma industry dynamics and the entities involved.
Article found on: www.stocktitan.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here